Azacitidine and venetoclax for post-transplant relapse in a case of CBFA2T3/GLIS2 childhood acute myeloid leukaemia

Pediatr Blood Cancer. 2021 Nov;68(11):e29221. doi: 10.1002/pbc.29221. Epub 2021 Jul 14.

Authors

Avijeet Kumar Mishra¹, Khushnuma Mullanfiroze², Robert Chiesa², Ajay Vora¹

Affiliations

¹ Department of Paediatric Haematology, Great Ormond Street Hospital, London, UK.
² Department of Bone Marrow Transplantation, Great Ormond Street Hospital, London, UK.

PMID: 34260140
DOI: 10.1002/pbc.29221

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Azacitidine* / therapeutic use
Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
Child
Humans
Kruppel-Like Transcription Factors
Leukemia, Myeloid, Acute* / drug therapy
Neoplasm Recurrence, Local
Repressor Proteins
Sulfonamides* / therapeutic use

Substances

Bridged Bicyclo Compounds, Heterocyclic
CBFA2T3 protein, human
GLIS2 protein, human
Kruppel-Like Transcription Factors
Repressor Proteins
Sulfonamides
Azacitidine
venetoclax